These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8099741)

  • 1. Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs.
    Ellenbroek BA
    Pharmacol Ther; 1993 Jan; 57(1):1-78. PubMed ID: 8099741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptics, dopamine, and schizophrenia.
    Pickar D
    Psychiatr Clin North Am; 1986 Mar; 9(1):35-48. PubMed ID: 2870480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
    Wiesel FA
    Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic latency of neuroleptic drugs and nonspecific postjunctional supersensitivity.
    Freed WJ
    Schizophr Bull; 1988; 14(2):269-77. PubMed ID: 2904695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor mechanisms in antipsychotic drug action: focus on sigma receptors.
    Snyder SH; Largent BL
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):7-15. PubMed ID: 2577720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
    Chouinard G; Annable L; Jones BD; Collu R
    Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Effects of Antipsychotic Drugs.
    Sánchez JPB; Ellenbroek BA
    Curr Top Behav Neurosci; 2017; 34():1-16. PubMed ID: 27356523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on a time-dependent model of neuroleptic action.
    Pickar D
    Schizophr Bull; 1988; 14(2):255-68. PubMed ID: 2904694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "neuroleptic" antipsychotic drugs. 1. Mechanisms of action.
    Baldessarini RJ
    Postgrad Med; 1979 Apr; 65(4):108-11, 114-9. PubMed ID: 34141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of new drugs for the treatment of schizophrenia.
    Cookson J
    Br J Hosp Med; 1987 Dec; 38(6):542-8. PubMed ID: 2893648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of quetiapine side effects.
    Garver DL
    J Clin Psychiatry; 2000; 61 Suppl 8():31-3; discussion 34-5. PubMed ID: 10811241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.
    Chouinard G; Jones BD
    Am J Psychiatry; 1980 Jan; 137(1):16-21. PubMed ID: 6101522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroquel: a putative atypical antipsychotic drug with serotonin- and dopamine-receptor antagonist properties. Preclinical and early clinical trials in schizophrenia.
    J Clin Psychiatry; 1995 Sep; 56(9):438-45. PubMed ID: 7665549
    [No Abstract]   [Full Text] [Related]  

  • 14. New antipsychotic agents and the future.
    Mackay AV
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):51-3. PubMed ID: 2858482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possible participation of limbic structures of the forebrain in the mechanism of the antipsychotic effect of neuroleptic preparations in schizophrenia (review)].
    Aksent'ev SB; Mokhovikov AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1254-60. PubMed ID: 6137921
    [No Abstract]   [Full Text] [Related]  

  • 16. Preclinical epigenetic models for screening epigenetic drugs for schizophrenia.
    Peedicayil J
    J Pharmacol Toxicol Methods; 2016; 77():1-5. PubMed ID: 26370661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does neuroleptic blocking of dopamine receptors continue after chronic treatment?
    Belmaker RH; Dasberg H; Ebstein RP
    Prog Biochem Pharmacol; 1980; 16():109-18. PubMed ID: 6108567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biochemical effects of neuroleptics].
    Petit M; Dollfus S
    Encephale; 1990; 16(2):71-98. PubMed ID: 1972057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance therapy and the natural course of schizophrenia.
    Davis JM
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):18-21. PubMed ID: 2865252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
    Truong DD; Sczesni B; Fahn S; Gross J; Donovan K; van Bakel A; Wiley MK
    Nervenarzt; 1988 Feb; 59(2):103-9. PubMed ID: 2896306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.